Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

Diabetologia

Volumn 44, Issue 9, 2001, Pages 1111-1117

  Kaser, S ^a   Sandhofer, A ^a   Foger B ^a   Ebenbichler, C F ^a   Igelseder, B ^c   Malaimare, L ^b   Paulweber, B ^b   Patsch, J R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b St Johanns Spital   (Austria)

^c Christian Doppler Klinik   (Austria)

Author keywords

Adipose tissue; Body mass index; Insulin sensitivity; Obesity; Phospholipid transfer protein

Indexed keywords

INSULIN; LEPTIN; PHOSPHOLIPID TRANSFER PROTEIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARRIER PROTEINS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LINEAR MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 0034840411     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100630     Document Type: Article

References (38)

1. Molecular biology of phospholipid transfer protein
2. Functional expression of human and mouse plasma phospholipid transfer protein: Effect of recombinant and plasma PLTP on HDL subspecies
3. Mammalian adipose tissue and muscle are major sources of lipid transfer protein m-RNA
4. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
5. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man
6. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat
7. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
8. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein
9. Phospholipid transfer protein mediated conversion of high density lipoproteins generates preB1-HDL
10. Early incorporation of cell-derived cholesterol into pre-beta-migrating high density lipoprotein
11. Human plasma phospholipid transfer protein increases the antiatherogenJc potential of high density lipoproteins in transgenic mice
12. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced uptake of phospholipids and cholesteryl esters from HDL
13. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice
14. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
15. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
16. Obesity
17. Overweight, obesity, and health risk
18. Body mass index and mortality in a prospective cohort of U.S. adults
19. Cardiovascular risk factors and medicare costs
20. Postprandial lipid and glucose metabolism in women undergoing moderate weight loss by diet plus exercise
21. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women
22. Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese type II diabetic patients
23. PLTP activity in premenopausal women: Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance
24. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
25. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration
26. The intravenous insulin tolerance test is an accurate method for screening a general population for insulin resistence and related abnormalities
27. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
28. Transfer of (14C)phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay
29. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma
30. Zonal ultracentrifugation
31. High density lipoprotein 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
32. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities
33. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
34. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
35. Impaired postprandial clearance of triacylgylcerol-rich lipoproteins in adipose tissue in obese subjects
36. Altered properties of high density lipoprotein subfractions in obese subjects
37. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIA hyperlipidemic, type IIB hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA
38. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man